Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
| Distributed by / for | Calvin Scott & Co., Inc. Albuquerque, NM 87123 |
| NDC | 16729-0184-17 |
| Full product label | Hydrochlorothiazide 50mg tablets, 14-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, Manufactured by Accord Healthcare, Inc., Durham NC 27703; NDC 16729-0184-17 |
| Recalling firm | Calvin Scott & Company, Inc. |
| Distribution | Nationwide within the United States |
| Quantity | N/A |
| Recall initiated | 2020-07-27 |
| Report date | 2020-08-26 |
| Recall completed | 2024-04-11 |
| Recall number | D-1516-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Albuquerque NM United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗